PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9685673-2	1998	Ibogaine and noribogaine were shown to have affinity for the serotonin transporter, and inhibition of serotonin reuptake has been proposed to be involved in their anti-addictive actions.	Ibogaine	0-8	solute carrier family 6 member 4	Rattus norvegicus	61-82	
10911925-11	2000	Ibogaine and its metabolite noribogaine have low microM affinities for kappa and mu opioid receptors, NMDA receptors, 5HT-3 receptors, sigma-2 sites, sodium channels and the serotonin transporter.	Ibogaine	0-8	solute carrier family 6 member 4	Rattus norvegicus	174-195	
9685673-9	1998	These and other data suggest that (1) the serotonergic system may not be an essential factor in the anti-addictive actions of these drugs; (2) ibogaine (or an unidentified metabolite) may release serotonin as well as inhibit its reuptake; (3) stimulation of the ascending serotonergic system may mediate ibogaine"s hallucinogenic effect; and (4) 18-MC probably has no affinity for the serotonin transporter, and is unlikely to be a hallucinogen.	Ibogaine	143-151	solute carrier family 6 member 4	Rattus norvegicus	385-406	
27140629-5	2016	Using membranes from HeLa cells expressing SERT and intact rat basophilic leukemia cells, we show that agents such as Na(+) and cocaine that stabilize outward-open conformations of SERT decreased phosphorylation and agents that stabilize inward-open conformations (e.g., 5-HT, ibogaine) increased phosphorylation.	Ibogaine	277-285	solute carrier family 6 member 4	Rattus norvegicus	181-185	
8880938-5	1996	Both ibogaine and 12-OH ibogamine demonstrated the highest potency values at the cocaine recognition site on the 5-HT transporter.	Ibogaine	5-13	solute carrier family 6 member 4	Rattus norvegicus	113-129